The Optimization of HAART for Chinese——a RCT Study
Phase of Trial: Phase IV
Latest Information Update: 27 Mar 2018
At a glance
- Drugs Efavirenz/lamivudine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 20 Mar 2018 Planned primary completion date changed from 1 Jun 2018 to 30 Jun 2019.
- 20 Mar 2018 Status changed from not yet recruiting to recruiting.
- 03 Nov 2016 New trial record